326 related articles for article (PubMed ID: 9475021)
1. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
Sharma A; Gupta R; Ram J; Gupta A
Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
[TBL] [Abstract][Full Text] [Related]
2. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
3. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
[TBL] [Abstract][Full Text] [Related]
4. Ketorolac: a new antiinflammatory for seasonal allergic conjunctivitis.
Holdcroft C
Nurse Pract; 1994 May; 19(5):30. PubMed ID: 8065646
[No Abstract] [Full Text] [Related]
5. The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.
Toker MI; Erdem H; Erdogan H; Arici MK; Topalkara A; Arslan OS; Pahsa A
Am J Ophthalmol; 2006 May; 141(5):902-905. PubMed ID: 16527227
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
Ballas Z; Blumenthal M; Tinkelman DG; Kriz R; Rupp G
Surv Ophthalmol; 1993; 38 Suppl():141-8. PubMed ID: 8236005
[TBL] [Abstract][Full Text] [Related]
8. Ketorolac for seasonal allergic conjunctivitis.
Med Lett Drugs Ther; 1993 Sep; 35(905):88-9. PubMed ID: 8361452
[No Abstract] [Full Text] [Related]
9. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
10. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
Tauber J; Raizman MB; Ostrov CS; Laibovitz RA; Abelson MB; Betts JG; Koester JM; Gill D; Schaich L
J Ocul Pharmacol Ther; 1998 Apr; 14(2):137-45. PubMed ID: 9572539
[TBL] [Abstract][Full Text] [Related]
11. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of ketorolac and dipyrone administered orally in the treatment of postoperative pain.
González-García CA; Ibarra-Ibarra LG; Barbosa-Vivanco S
Proc West Pharmacol Soc; 1994; 37():121-2. PubMed ID: 7984640
[No Abstract] [Full Text] [Related]
13. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Stewart R; Grosserode R; Cheetham JK; Rosenthal A
Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer.
Minotti V; Betti M; Ciccarese G; Fumi G; Tonato M; Del Favero A
Pharmacotherapy; 1998; 18(3):504-8. PubMed ID: 9620101
[TBL] [Abstract][Full Text] [Related]
15. A critical look at ocular allergy drugs.
Joseph Titi M
Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
[TBL] [Abstract][Full Text] [Related]
16. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
Gupta V; Sahu PK
Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
[TBL] [Abstract][Full Text] [Related]
17. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
Uchio E; Itoh Y; Kadonosono K
Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
[TBL] [Abstract][Full Text] [Related]
18. Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.
Raizman MB
Clin Ther; 1995; 17(5):882-90. PubMed ID: 8595640
[TBL] [Abstract][Full Text] [Related]
19. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis.
Williams CP; Browning AC; Sleep TJ; Webber SK; McGill JI
Eye (Lond); 2005 Jul; 19(7):739-42. PubMed ID: 15359265
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
